Trials / Withdrawn
WithdrawnNCT00233636
Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
A 2 Part Phase 2 Trial to Evaluate ZD1839 (Iressa™) & Radiotherapy in Patients w/Locally Advanced Inoperable Squamous Cell Carcinoma of the Head & Neck
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine if Iressa added to radiotherapy is effective and safe in shrinking tumour dimensions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iressa (Gefitinib) | |
| PROCEDURE | Radiotherapy |
Timeline
- Start date
- 2003-07-01
- First posted
- 2005-10-06
- Last updated
- 2011-01-27
Locations
6 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00233636. Inclusion in this directory is not an endorsement.